Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,317-2,328 of 4,306
Other study type icon
CompletedNCT00984373

Epidemiology of Schizophrenia in Bulgaria

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Burgas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Bulgaria
Sponsor
AstraZeneca
Condition
Schizophrenia
Other study type icon
CompletedNCT01021449

Epigenetic Regulation of BDNF in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Kaohsiung City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
Chang Gung Memorial Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00456937

Escitalopram in Schizophrenia in OCD- Open Label Study

This summary needs review. Please check the official study record and contact the research team for details.

In Beer Yaakov
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, OCDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Israel
Sponsor
BeerYaakov Mental Health Center
Condition
Schizophrenia, OCD
Other study type icon
UnknownNCT05206292

Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in people with Psychotic Disorders.

This summary needs review. Please check the official study record and contact the research team for details.

In Grenoble
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
France
Sponsor
University Hospital, Grenoble
Condition
Schizophrenia
Drug study icon
CompletedNCT02146547

European Long-acting Antipsychotics in Schizophrenia study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United Kingdom, Belgium, Austria, ...
Sponsor
UMC Utrecht
Condition
Schizophrenia
Drug study icon
CompletedNCT04572685

Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection for schizophrenia

This study is completed in the United States. It is testing Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection for schizophrenia.

In Berlin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01891721

Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 25 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Other study type icon
CompletedNCT01378403

Evaluation of Dorsal Visual Stream in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Ramat Gan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 35 Years
Countries
Israel
Sponsor
Sheba Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT00334126

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03338179

Evaluation of Metamemory in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Clermont-Ferrand
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
France
Sponsor
University Hospital, Clermont-Ferrand
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.